{"transactions":[{"id":1031885,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":74939,"kind":"organization","name":"Tactic Pharma LLC","position":1,"cik":"0001727357","reported_name":"Tactic Pharma LLC","relationship":{"ten_percent_owner":true}},{"id":32623,"kind":"person","name":"Robinson Chandler","position":2,"cik":"0001727334","reported_name":"Robinson Chandler","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}},{"id":64053,"kind":"person","name":"Brown Michael J","position":3,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"other":true,"other_text":"Member of 10% Owner Group"}},{"id":74940,"kind":"person","name":"O'Halloran Thomas V.","position":4,"cik":"0001727481","reported_name":"O'Halloran Thomas V.","relationship":{"other":true,"other_text":"Member of 10% Owner Group"}},{"id":54676,"kind":"person","name":"Mazar Andrew Paul","position":5,"cik":"0001727393","reported_name":"Mazar Andrew Paul","relationship":{"other":true,"other_text":"Member of 10% Owner Group"}}],"security":"Common Stock","published_at":"2025-09-26T15:53:30.000Z","date":"2025-09-24","kind":"sale","planned":false,"acquired":false,"shares":550229,"price":63.6098,"value":34999956.6442,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"This Form 4 is being filed on behalf of Tactic Pharma LLC, an Illinois limited liability company (\"Tactic\"), and its managers, Andrew P. Mazar, Chandler D. Robinson, Michael J. Brown, and Thomas V. O'Halloran (collectively, the \"Reporting Persons\"). The managers collectively have voting control over the securities described herein. The managers each disclaim ownership of the shares of common stock owned by Tactic, except to the extent of their pecuniary interest therein. The Reporting Persons are no longer subject to Section 16, except for Chandler D. Robinson, who serves as Chief Executive Officer of Monopar Therapeutics Inc."}],"balance_after":272026,"source":{"system":"sec-edgar","filing":"0001437749-25-029925","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000143774925029925/rdgdoc.xml","form_type":"4"}},{"id":1177879,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":74939,"kind":"organization","name":"Tactic Pharma LLC","position":1,"cik":"0001727357","reported_name":"Tactic Pharma LLC","relationship":{"ten_percent_owner":true}},{"id":32623,"kind":"person","name":"Robinson Chandler","position":2,"cik":"0001727334","reported_name":"Robinson Chandler","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}},{"id":64053,"kind":"person","name":"Brown Michael J","position":3,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"other":true,"other_text":"Member of 10% Owner Group"}},{"id":74940,"kind":"person","name":"O'Halloran Thomas V.","position":4,"cik":"0001727481","reported_name":"O'Halloran Thomas V.","relationship":{"other":true,"other_text":"Member of 10% Owner Group"}},{"id":54676,"kind":"person","name":"Mazar Andrew Paul","position":5,"cik":"0001727393","reported_name":"Mazar Andrew Paul","relationship":{"other":true,"other_text":"Member of 10% Owner Group"}}],"security":"Common Stock","published_at":"2025-04-04T19:27:32.000Z","date":"2025-04-02","kind":"sale","planned":false,"acquired":false,"shares":33334,"price":35,"value":1166690.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.86, inclusive. The reporting person undertakes to provide to Monopar Therapeutics Inc., any security holder of Monopar Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This Form 4 is being filed on behalf of Tactic Pharma LLC, an Illinois limited liability company (\"Tactic\"), and its managers, Andrew P. Mazar, Chandler D. Robinson, Michael J. Brown, and Thomas V. O'Halloran (collectively, the \"Reporting Persons\"). The managers collectively have voting control over the securities described herein. The managers each disclaim ownership of the shares of common stock owned by Tactic, except to the extent of their pecuniary interest therein."}],"balance_after":822255,"source":{"system":"sec-edgar","filing":"0001437749-25-011068","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000143774925011068/rdgdoc.xml","form_type":"4"}},{"id":2859929,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":74939,"kind":"organization","name":"Tactic Pharma LLC","position":1,"cik":"0001727357","reported_name":"Tactic Pharma LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true}},{"id":54676,"kind":"person","name":"Mazar Andrew Paul","position":2,"cik":"0001727393","reported_name":"Mazar Andrew Paul","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"officer_title":"Chief Scientific Officer"}},{"id":32623,"kind":"person","name":"Robinson Chandler","position":3,"cik":"0001727334","reported_name":"Robinson Chandler","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"officer_title":"Chief Executive Officer"}},{"id":74940,"kind":"person","name":"O'Halloran Thomas V.","position":4,"cik":"0001727481","reported_name":"O'Halloran Thomas V.","relationship":{"director":false,"officer":false,"ten_percent_owner":true}},{"id":64053,"kind":"person","name":"Brown Michael J","position":5,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common stock","published_at":"2021-02-16T19:35:11.000Z","date":"2021-02-11","kind":"sale","acquired":false,"shares":11929,"price":16.9,"value":201600.1,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on November 24, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.77 to $17.01, inclusive."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This Form 4 is being filed on behalf of Tactic Pharma LLC, an Illinois limited liability company (\"Tactic\"), and its managers, Andrew P. Mazar, Chandler D. Robinson, Michael J. Brown, and Thomas V. O'Halloran (collectively, the \"Reporting Persons\"). The managers collectively have voting control over the securities described herein. The managers each disclaim ownership of the shares of common stock owned by Tactic, except to the extent of their pecuniary interest therein."}],"balance_after":166667,"source":{"system":"sec-edgar","filing":"0001654954-21-001750","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000165495421001750/section16.xml","form_type":"4"}},{"id":2859928,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":74939,"kind":"organization","name":"Tactic Pharma LLC","position":1,"cik":"0001727357","reported_name":"Tactic Pharma LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true}},{"id":54676,"kind":"person","name":"Mazar Andrew Paul","position":2,"cik":"0001727393","reported_name":"Mazar Andrew Paul","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"officer_title":"Chief Scientific Officer"}},{"id":32623,"kind":"person","name":"Robinson Chandler","position":3,"cik":"0001727334","reported_name":"Robinson Chandler","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"officer_title":"Chief Executive Officer"}},{"id":74940,"kind":"person","name":"O'Halloran Thomas V.","position":4,"cik":"0001727481","reported_name":"O'Halloran Thomas V.","relationship":{"director":false,"officer":false,"ten_percent_owner":true}},{"id":64053,"kind":"person","name":"Brown Michael J","position":5,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common stock","published_at":"2021-02-16T19:35:11.000Z","date":"2021-02-11","kind":"sale","acquired":false,"shares":16384,"price":16.44,"value":269352.96,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on November 24, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.77 to $16.76, inclusive."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This Form 4 is being filed on behalf of Tactic Pharma LLC, an Illinois limited liability company (\"Tactic\"), and its managers, Andrew P. Mazar, Chandler D. Robinson, Michael J. Brown, and Thomas V. O'Halloran (collectively, the \"Reporting Persons\"). The managers collectively have voting control over the securities described herein. The managers each disclaim ownership of the shares of common stock owned by Tactic, except to the extent of their pecuniary interest therein."}],"balance_after":178596,"source":{"system":"sec-edgar","filing":"0001654954-21-001750","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000165495421001750/section16.xml","form_type":"4"}},{"id":2859927,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":74939,"kind":"organization","name":"Tactic Pharma LLC","position":1,"cik":"0001727357","reported_name":"Tactic Pharma LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true}},{"id":54676,"kind":"person","name":"Mazar Andrew Paul","position":2,"cik":"0001727393","reported_name":"Mazar Andrew Paul","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"officer_title":"Chief Scientific Officer"}},{"id":32623,"kind":"person","name":"Robinson Chandler","position":3,"cik":"0001727334","reported_name":"Robinson Chandler","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"officer_title":"Chief Executive Officer"}},{"id":74940,"kind":"person","name":"O'Halloran Thomas V.","position":4,"cik":"0001727481","reported_name":"O'Halloran Thomas V.","relationship":{"director":false,"officer":false,"ten_percent_owner":true}},{"id":64053,"kind":"person","name":"Brown Michael J","position":5,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common stock","published_at":"2021-02-16T19:35:11.000Z","date":"2021-02-11","kind":"sale","acquired":false,"shares":29996,"price":15.12,"value":453539.52,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on November 24, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.76 to $15.75, inclusive."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This Form 4 is being filed on behalf of Tactic Pharma LLC, an Illinois limited liability company (\"Tactic\"), and its managers, Andrew P. Mazar, Chandler D. Robinson, Michael J. Brown, and Thomas V. O'Halloran (collectively, the \"Reporting Persons\"). The managers collectively have voting control over the securities described herein. The managers each disclaim ownership of the shares of common stock owned by Tactic, except to the extent of their pecuniary interest therein."}],"balance_after":194980,"source":{"system":"sec-edgar","filing":"0001654954-21-001750","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000165495421001750/section16.xml","form_type":"4"}},{"id":2859926,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":74939,"kind":"organization","name":"Tactic Pharma LLC","position":1,"cik":"0001727357","reported_name":"Tactic Pharma LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true}},{"id":54676,"kind":"person","name":"Mazar Andrew Paul","position":2,"cik":"0001727393","reported_name":"Mazar Andrew Paul","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"officer_title":"Chief Scientific Officer"}},{"id":32623,"kind":"person","name":"Robinson Chandler","position":3,"cik":"0001727334","reported_name":"Robinson Chandler","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"officer_title":"Chief Executive Officer"}},{"id":74940,"kind":"person","name":"O'Halloran Thomas V.","position":4,"cik":"0001727481","reported_name":"O'Halloran Thomas V.","relationship":{"director":false,"officer":false,"ten_percent_owner":true}},{"id":64053,"kind":"person","name":"Brown Michael J","position":5,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common stock","published_at":"2021-02-16T19:35:11.000Z","date":"2021-02-11","kind":"sale","acquired":false,"shares":24224,"price":14.09,"value":341316.16,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on November 24, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.66 to $14.54, inclusive."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This Form 4 is being filed on behalf of Tactic Pharma LLC, an Illinois limited liability company (\"Tactic\"), and its managers, Andrew P. Mazar, Chandler D. Robinson, Michael J. Brown, and Thomas V. O'Halloran (collectively, the \"Reporting Persons\"). The managers collectively have voting control over the securities described herein. The managers each disclaim ownership of the shares of common stock owned by Tactic, except to the extent of their pecuniary interest therein."}],"balance_after":224976,"source":{"system":"sec-edgar","filing":"0001654954-21-001750","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000165495421001750/section16.xml","form_type":"4"}},{"id":2859925,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":74939,"kind":"organization","name":"Tactic Pharma LLC","position":1,"cik":"0001727357","reported_name":"Tactic Pharma LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true}},{"id":54676,"kind":"person","name":"Mazar Andrew Paul","position":2,"cik":"0001727393","reported_name":"Mazar Andrew Paul","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"officer_title":"Chief Scientific Officer"}},{"id":32623,"kind":"person","name":"Robinson Chandler","position":3,"cik":"0001727334","reported_name":"Robinson Chandler","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"officer_title":"Chief Executive Officer"}},{"id":74940,"kind":"person","name":"O'Halloran Thomas V.","position":4,"cik":"0001727481","reported_name":"O'Halloran Thomas V.","relationship":{"director":false,"officer":false,"ten_percent_owner":true}},{"id":64053,"kind":"person","name":"Brown Michael J","position":5,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common stock","published_at":"2021-02-16T19:35:11.000Z","date":"2021-02-11","kind":"sale","acquired":false,"shares":42467,"price":13.3,"value":564811.1,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on November 24, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.66 to $13.65, inclusive. The\nreporting person undertakes to provide to Monopar Therapeutics Inc., any security holder of Monopar Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (7) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This Form 4 is being filed on behalf of Tactic Pharma LLC, an Illinois limited liability company (\"Tactic\"), and its managers, Andrew P. Mazar, Chandler D. Robinson, Michael J. Brown, and Thomas V. O'Halloran (collectively, the \"Reporting Persons\"). The managers collectively have voting control over the securities described herein. The managers each disclaim ownership of the shares of common stock owned by Tactic, except to the extent of their pecuniary interest therein."}],"balance_after":249200,"source":{"system":"sec-edgar","filing":"0001654954-21-001750","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000165495421001750/section16.xml","form_type":"4"}},{"id":3334113,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":74939,"kind":"organization","name":"Tactic Pharma LLC","position":1,"cik":"0001727357","reported_name":"Tactic Pharma LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true}},{"id":54676,"kind":"person","name":"Mazar Andrew Paul","position":2,"cik":"0001727393","reported_name":"Mazar Andrew Paul","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Scientific Officer"}},{"id":32623,"kind":"person","name":"Robinson Chandler","position":3,"cik":"0001727334","reported_name":"Robinson Chandler","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}},{"id":74940,"kind":"person","name":"O'Halloran Thomas V.","position":4,"cik":"0001727481","reported_name":"O'Halloran Thomas V.","relationship":{"director":false,"officer":false,"ten_percent_owner":true}},{"id":64053,"kind":"person","name":"Brown Michael J","position":5,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":true}}],"security":"Common stock","published_at":"2019-12-20T18:33:25.000Z","date":"2019-12-18","kind":"purchase","acquired":true,"shares":125000,"price":8,"value":1000000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"This Form 4 is being filed on behalf of Tactic Pharma LLC, an Illinois limited liability company (\"Tactic\"), and its managers, Andrew P. Mazar, Chandler D. Robinson, Michael J. Brown, and Thomas V. O'Halloran (collectively, the \"Reporting Persons\"). The managers collectively have voting control over the securities described herein. The managers each disclaim ownership of the shares of common stock owned by Tactic, except to the extent of their pecuniary interest therein."}],"balance_after":291667,"source":{"system":"sec-edgar","filing":"0001654954-19-014150","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000165495419014150/section16.xml","form_type":"4"}}]}